Mydecine Innovations Group Inc.
MYCO.NE
CBOE CA0.35
CAD
- -
- -
Total Valuation
Mydecine Innovations Group Inc. carries a market capitalization of 21.42M, placing it among publicly traded companies globally.
| Market Cap | 21.42M |
| Enterprise Value | N/A |
Stock Price Statistics
Mydecine Innovations Group Inc.'s stock has gained approximately 6900% over the past 52 weeks. The 50-day moving average sits at 0.15, while the 200-day moving average is 0.15.
| Beta (5Y) | N/A |
| 52-Week Price Change | 6900% |
| 50-Day Moving Average | 0.15 |
| 200-Day Moving Average | 0.15 |
| Average Volume (20 Days) | N/A |
Stock Splits
Mydecine Innovations Group Inc.'s most recent stock split took place on April 21, 2022 with a 50:1 split ratio.
| Last Split Date | 4/21/2022 |
| Split Ratio | 50:1 |